Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-067464
Filing Date
2026-02-24
Accepted
2026-02-24 17:07:45
Documents
77
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K crdf-20251231.htm   iXBRL 10-K 2694914
2 EX-10.15 crdf-ex10_15.htm EX-10.15 186297
3 EX-23.1 crdf-ex23_1.htm EX-23.1 3712
4 EX-31.1 crdf-ex31_1.htm EX-31.1 14562
5 EX-31.2 crdf-ex31_2.htm EX-31.2 14448
6 EX-32.1 crdf-ex32_1.htm EX-32.1 8642
7 EX-32.2 crdf-ex32_2.htm EX-32.2 8521
8 GRAPHIC img3640904_0.gif GRAPHIC 8550
  Complete submission text file 0001193125-26-067464.txt   11477766

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crdf-20251231.xsd EX-101.SCH 1209089
79 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20251231_htm.xml XML 2490097
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35558 | Film No.: 26672837
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)